Möchten Sie immer auf dem neuesten Stand bleiben?

LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2026

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 19, 2026 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN) (the...

Sheridan, Wyoming, June 19, 2026 (GLOBE NEWSWIRE) -- Clevio announced RoboClean, a robotic window-cleaning device designed to help homeowners clean high and difficult-to-reach windows without the...

Sheridan, Wyoming, June 19, 2026 (GLOBE NEWSWIRE) -- As demand grows for practical products that make daily routines easier, Osmo is expanding its focus on affordable smart-living solutions designed...

REGULATED INFORMATIONJune 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to...

INFORMATIONS RÉGLEMENTÉESLe 19 juin 2026, 22:30h CET / 16:30h ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique(ci-après la « Société ») Invitation...

NOVATO, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...

HOUSTON, June 19, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) will host a conference call on Wednesday, July 22, 2026 to discuss the...

SHERMAN OAKS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Dr. Austin Harris, MD, founder of NeuroRelief Ketamine & Infusion Therapy, has announced the availability of NAD+ IV infusion therapy as...

CAMBRIDGE, Mass., June 19, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of...